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S U M M A R Y
Objectives: Seasonal variations in ultraviolet B (UVB) radiation cause seasonal variations in vitamin D
status. This may inﬂuence immune responses and play a role in the seasonality of inﬂuenza.
Methods: Pandemic and non-pandemic inﬂuenzas in Sweden, Norway, the USA, Singapore, and Japan
were studied. Weekly/monthly inﬂuenza incidence and death rates were evaluated in view of monthly
UVB ﬂuences.
Results: Non-pandemic inﬂuenzas mostly occur in the winter season in temperate regions. UVB
calculations show that at high latitudes very little, if any, vitamin D is produced in the skin during the
winter. Even at 268N (Okinawa) there is about four times more UVB during the summer than during the
winter. In tropical regions there are two minor peaks in vitamin D photosynthesis, and practically no
seasonality of inﬂuenza. Pandemicsmay start with awave in an arbitrary season, while secondarywaves
often occur the following winter. Thus, it appears that a low vitamin D status may play a signiﬁcant role
in most inﬂuenzas.
Conclusions: In temperate latitudes even pandemic inﬂuenzas often show a clear seasonality. The data
support the hypothesis that high ﬂuences of UVB radiation (vitamin D level), as occur in the summer, act
in a protective manner with respect to inﬂuenza.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Nearly all human diseases related to respiratory pathogens
exhibit seasonal variations.1,2 However, the reasons for this
seasonality are still not known. Among the tested hypotheses
are: seasonality of low temperatures, absolute humidity (aerosol
transmission), or of dry air, crowding together indoors during the
winter, travel patterns, vacations, seasonality of ultraviolet (UV)
radiation from the sun that might kill pathogens, circannual
rhythms of hormones, such as the ‘dark hormone’ melatonin,
etc.1,3–8 Another founded hypothesis is that seasonal variations in
UVB radiation and consequently vitamin D photosynthesis,
causing seasonal variations in vitamin D status,9,10 which plays
a role in the immune response to infections, may be responsible for
the inﬂuenza seasonality.9–15 Additionally, the question of
whether it is the host or the virus/bacterium that exhibits
seasonality arises. However, there are exceptions from seasonality,
notably for pandemic inﬂuenzas, which often occur outside the* Corresponding author. Tel.: +47 22934260; fax: +47 22781207.
E-mail address: asta.juzeniene@rr-research.no (A. Juzeniene).
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doi:10.1016/j.ijid.2010.09.002winter inﬂuenza seasons. Furthermore, in equatorial regions the
seasonal pattern is weak.2,16
In the present work we have compared the seasonality of cases
and deaths caused by both pandemic and non-pandemic
inﬂuenzaswith doses of UVB radiation (vitaminD photosynthesis).
Inﬂuenza may cause death either directly (due to a primary
complication caused by the inﬂuenza virus) or indirectly (due to
secondary non-inﬂuenza complications either pulmonary or non-
pulmonary in nature).17,18 Recent studies have indicated that the
majority of deaths in previous inﬂuenza pandemics have been a
result of secondary bacterial pneumonias.18–21 In this paper all
deaths related to inﬂuenza are referred to as ‘inﬂuenza deaths’
without further speciﬁcation.
2. Materials and methods
2.1. Inﬂuenza cases and deaths
Data from various sources were used in the present study
(Figures 1–6). The numbers of weekly Russian inﬂuenza cases in
Sweden (Figure 1) are from the publication by Skog et al.22 The
monthly death cases from inﬂuenza in Norway during 1980–1999ses. Published by Elsevier Ltd. All rights reserved.
[(Figure_1)TD$FIG]
Figure 1. Numbers of infected persons (&) per Thiessen area in Sweden for each
week from 1889 to 1890 during the Russian ﬂu, obtained from Skog et al.22 Weekly
photosynthesis of vitamin D (—*—) for a relevant latitude (Oslo, 608N) was
calculated by use of the vitamin D action spectrum, UV measurements, and
radiative transfer calculations (see Materials and methods).
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Figure 3.Weekly Spanish inﬂuenza death rates in Baltimore (398N), Augusta (338N),
and San Francisco (378N) from 1918 to 1919, taken from Britten.23
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death rates of the Spanish ﬂu in some American cities (Figure 3)
were obtained from the work of Britten.23 Monthly death rates
from 10 non-pandemic and two pandemic inﬂuenza seasons in the
USA during 1941–1976 (Figure 4) are from the publication by
Doshi.24 The pattern of monthly inﬂuenza cases in Okinawa from
2001 to 2007 (Figure 6) are from Suzuki et al.,25 while the data for
Singapore from 1990 to 1994 (Figure 5) are from the publication by
Chew et al.26
2.2. Solar exposure and seasonal vitamin D synthesis in human skin
The main factors inﬂuencing UV irradiance at ground level are
solar zenith angle (variable with season, latitude, and time of day),
cloud and snow cover, aerosols, and the thickness of the ozone
layer.27 In this study, global solar UV irradiances were calculated
using a radiative transfer model.28,29 Daily total ozone amounts
used in this model were measured by the Total Ozone Mapping
Spectrometer (TOMS) onboard the Earth Probe satellite. The daily
cloud cover used in our model was derived from reﬂectivity
measurements by TOMS. The errors in ozone derived from TOMS
instruments onboard several satellites are generally less than
2%.30,31 Not included in our calculations were atmospheric
aerosols, which may potentially have an impact on the solar
irradiance reaching the earth’s surface.32–34
The calculated monthly UV exposures were based on the
satellite measurements in the period 1997–2004. A cylinder
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Figure 2. The monthly inﬂuenza deaths (&) from 1980 to 1999 in Norway,
extracted fromMoan et al.14 Monthly photosynthesis of vitamin D (—*—) for Oslo
(608N) was calculated by use of the vitamin D action spectrum, UV measurements,
and radiative transfer calculations (see Materials and methods).geometry of the human body was used. The arguments for such a
choice have been presented previously.35,36
Results are presented as vitamin D-forming UV doses. The
efﬁciency spectrum for vitamin D production gives the relative
effectiveness of solar radiation at different wavelengths in
converting 7-dehydrocholesterol (7-DHC) to previtamin D. An
efﬁciency spectrum is calculated by multiplying the intensity of
the solar radiation (wavelength by wavelength) with the action
spectrum for vitamin D production for the correspondingFigure 4. Themonthly death rates from two pandemic (A) and 10 non-pandemic (B
and C) inﬂuenza seasons in the USA during 1941–1976; data fromDoshi.24 Monthly
photosynthesis of vitamin D for San Francisco (378N) and Baltimore (398N) was
calculated by use of the vitamin D action spectrum, UV measurements, and
radiative transfer calculations (see Materials and methods).
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Figure 5. The pattern of mean monthly inﬂuenza A cases (&) from 1990 to 1994 in
Singapore; data from Chew et al.26 Monthly photosynthesis of vitamin D (—*—) for
Singapore (18N) was calculated by use of the vitamin D action spectrum, UV
measurements, and radiative transfer calculations (see Materials and methods).
A. Juzeniene et al. / International Journal of Infectious Diseases 14 (2010) e1099–e1105 e1101wavelength. The vitamin D action spectrum was taken from the
publication of Galkin and Terentskaya,37 and is similar to that
measured by MacLaughlin et al. in ex vivo skin specimens.38 This
action spectrum is being used by a large number of investigators,
but is not ideal.
3. Results and discussion
3.1. Pandemic and non-pandemic inﬂuenzas
There are three types of inﬂuenza virus: inﬂuenza A virus,
inﬂuenza B virus, and inﬂuenza C virus.39 Inﬂuenza A viruses are
themost important because they generally cause severe secondary
diseases and often cause seasonal epidemics and pandemics.40,41
Inﬂuenza B is less common than inﬂuenza A, but can periodically
cause large epidemics, although not pandemics.40 Inﬂuenza C virus
is less common than inﬂuenza A and B, and diseases caused by this
species are generally much milder; it is not thought to cause
epidemics.40,42 Inﬂuenzas mainly attack weaker persons in a
population, such as children, the elderly, and the immune
incompetent.39
The best known and documented inﬂuenza pandemics are the
Russian ﬂu (1889–1890, about 1 million deaths), the Spanish ﬂu
(1918–1919, about 50 million deaths worldwide), the Asian ﬂu
(1957–1958, about 2 million deaths worldwide), and the Hong
Kong ﬂu (1968–1969 about 0.7 million deaths worldwide).43,44 In
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Figure 6. The mean number of monthly inﬂuenza cases (&) from 2001 to 2007 in
Okinawa, adapted from Suzuki et al.25 Monthly photosynthesis of vitamin D (—*—)
for Okinawa (268N) was calculated by use of the vitamin D action spectrum, UV
measurements, and radiative transfer calculations (see Materials and methods).April 2009, a novel H1N1 inﬂuenza A virus, the so-called pandemic
H1N1/09 virus (swine inﬂuenza, Mexican ﬂu, North American ﬂu)
was identiﬁed in Mexico.45–47 The virus has since spread
throughout the world and has caused an inﬂuenza pandemic,
but it has not exhibited unusually high pathogenecity.21 The full
impact of the current pandemic is not yet clear.47,48 According to
the World Health Organization (WHO), more than 209 countries
have reported laboratory conﬁrmed cases of pandemic inﬂuenza
H1N1 2009, and there have been at least 14 142 deaths.49
The spread of Russian pandemic inﬂuenza, caused by the
inﬂuenza A virus subtype H2N2, was extremely rapid. The Russian
ﬂu was ﬁrst detected in Bokara (Central Asia) in May 1889, quickly
reached St Petersburg in October, and 6 weeks later was registered
in the UK.22,44,50 In mid-December 1889 the ﬂu was reported in
North America and in North and South Africa; in February 1890 it
was reported in Latin America and in Asia and in March in New
Zealand, Australia, and East Africa.43,51 In Sweden, Russian ﬂu
occurred in the winter, with maximal numbers of infected persons
between mid-December 1889 and late January 1890 (Figure 1),22
almost coinciding in time with the seasonal (non-pandemic)
inﬂuenza deaths in Norway (Figure 2).14 We can conclude that in
temperate latitudes even pandemic inﬂuenzas may appear with a
clear winter seasonality of incidence and mortality.
The Spanish ﬂu, caused by inﬂuenza A virus subtype H1N1, is
sometimes referred to as ‘the mother of all pandemics’, because
since 1919 almost all inﬂuenza A pandemics have been caused by
descendants of this virus.52 It is still uncertain whether the ﬁrst
wave of the Spanish ﬂu occurred in Europe or in America.44,53–55
The ﬁrst wave of the pandemic in European countries was in the
spring and summer of 1918. It was highly contagious, but caused
few deaths.56 The second and largest peak was the most serious
and occurred in October 1918.56 The third, most long-lasting
pandemic wave started in February 1919.56 Inﬂuenza-related
mortality rates were high, ranging from 0.2 to 11 deaths per 1000
inhabitants in European countries.56
In the USA, the ﬁrst wave of the Spanish ﬂu occurred in March
1918.52,55,57 The second lethal wave peaked in the autumn of 1918,
and was responsible for most of the deaths, just as in Europe.
However, in Europe, only one autumn wave was seen in most
cities, whereas many of the USA cities had two peaks of mortality,
spaced by only a fewweeks (Figure 3).58 The secondwave probably
spread from the east coast to the west coast, because the highest
death rates were registered on October 19 in Baltimore (398N,
768W), on October 26 in Augusta (338N, 818W), and onNovember 5
in San Francisco (378N, 1228W) (Figure 3).23 The third wave came
in the classical inﬂuenza season (Figure 3).23 In Baltimore the
winter wave was weak and came later, while in the other cities it
came in mid-January (Figure 3), i.e., when the vitamin D
photosynthesis rate is at its minimum (Figure 4A). One possible
mechanism explaining the differences in death rates between the
summer, autumn and winter waves of the Spanish ﬂu could be
related to serum vitamin D levels and pre-existing heterosubtypic
immunity, probably induced by prior exposure to different
subtypes of inﬂuenza.59
However, this pattern of three waves was not universal:
Australia, for example, due to the partial success of a maritime
quarantine that delayed the outbreak until early in 1919,
experienced a single, longer wave of inﬂuenza activity.60–62 The
Spanish ﬂu came in two waves in Singapore (18N), a tropical island
city-state: in June–July and in October–November 1918,63,64 i.e.,
later than the ﬁrst wave in Europe and in the USA.
Arguments for the role of UVB and vitamin D in Spanish ﬂu in
the USA have been reviewed previously.15 The lowest pneumonia
and inﬂuenza mortality rates were seen in the areas with the
highest solar UVB irradiance and lowest latitudes (these being
good indicators for high levels of vitamin D), while the highest
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latitudes (indicators of low vitamin D levels).15
The Asian pandemic inﬂuenza originated in the southwest of
China in February 1957 (i.e., in the inﬂuenza season).2 It reached
Hong Kong in April, and then spread rapidly to Singapore, Taiwan,
and Japan. The causative agent, an inﬂuenza AH2N2 virus, was ﬁrst
isolated in Japan inMay 1957. This virus was found in June 1957 in
the UK and in July 1957 in the USA, but the peak of inﬂuenza
incidence and mortality occurred in October 1957.2,54,65 This ﬁrst
wave of disease in North America and in Europe was followed by a
second wave in January–February 1958, again in the inﬂuenza
season.2,54,65
The Hong Kong inﬂuenza A virus subtype H3N2 was ﬁrst
isolated in Hong Kong in July 1968, and in September it was
registered in Japan, the USA, England and Wales; it was registered
in France in January 1969.66 Despite the rapid and extensive spread
of this virus, its impact was not the same in all geographical
regions: in North America, themajority of inﬂuenza-related deaths
occurred during the ﬁrst pandemic season ((1968/1969), while in
Europe most deaths occurred during the second pandemic season
(1969/1970). The highest rates of inﬂuenza cases and mortality
were observed during the winter in all studied countries (the USA,
Canada, England and Wales, France, Japan, and Australia).66,67
Thus, these two pandemics, the Asian ﬂu and the Hong Kong ﬂu,
followed an almost classical trend with high winter death rates,
similar to non-pandemic seasonal inﬂuenzas in theUSA (Figure 4, B
and C).24 Both of these pandemics occurred in Singapore,which has
almost no incidence variations in seasonal inﬂuenzas (see
below).64,68 The Asian inﬂuenza pandemic in Singapore started
in May 1957 (earlier than in the USA, Figure 4A), and the Hong
Kong inﬂuenza pandemic ﬁrst occurred in August–early Septem-
ber 1968 (also earlier than in the USA, Figure 4A).64
All seasonal inﬂuenzas in the period from 1941 to 1976 in the
USA followed a similar winter trend, with the exceptions of the
1946–1947 and the 1975–1976waves, which came late, peaking in
March–April (Figure 4, B and C).24 However, thesewaves also came
before the vitamin D levels start to increase after the winter
(Figure 4A).
3.2. Seasonal variations in vitamin D photosynthesis and non-
pandemics
The monthly variations in vitamin D photosynthesis in human
skin in some selected countries were calculated using the action
spectrum of Galkin and Terentskaya37 and assuming cylinder
geometry.35,36 As shown in our earlier studies of the Nordic
countries,69 the vitamin D level is maximal about amonth after the
time of maximal rate of synthesis, which occurs close to
midsummer. This is due to the fact that the vitamin D level here
is determined as the concentration of 25-hydroxyvitamin D in
serum, and that the formation of this metabolite from previtamin
D, via vitamin D (mainly in the liver), takes around one week.70
Above 378 latitude, very low UVB ﬂuences reach the ground during
themonths of November through February.71 Therefore, very little,
if any, vitamin D is produced in the skin during the winter. In fact,
the lowest vitamin D levels are found in February–March.71
Seasonal variations in vitamin D photosynthesis decrease as the
equator is approached (Figure 5). In fact, as the curve for Singapore
(18N) shows (Figure 5), there are two minor maxima per year,
located almost symmetrically around the midsummer minimum.
The reasonswhy the symmetry is not complete are the slight ozone
asymmetry and changes in cloud cover, which were both taken
into account when we calculated the curves in Figure 5. November
and December are the months of the rainy season in Singapore. In
this city there is almost no seasonality of inﬂuenza,26,64,72 as might
be expected from the small seasonal variation in vitamin Dphotosynthesis (Figure 5). However, a small seasonal variation in
inﬂuenza has been observed, with small peaks in June and
December–January.26,64,72 It appears that the inﬂuenzawaves start
during periods of low vitamin D photosynthesis. These peaks may
be related to humidity, or possibly to contamination from seasonal
inﬂuenzas in the southern and northern hemisphere, and to the
seasonal variation in vitamin D photosynthesis (Figure 5).
For the subtropical region, inﬂuenza data are available for
Okinawa (268N) and Taiwan (238N).25,73 In both of these places
there is a regular, major outbreak of inﬂuenza in the winter and a
minor outbreak in the summer. This pattern is also characteristic of
inﬂuenza circulation in other subtropical areas.74 In these places
there is signiﬁcant vitamin D photosynthesis throughout the year,
but it should be noted that the winter rate is only a fourth of the
summer rate (Figure 6).
In the USA, non-pandemics of inﬂuenza typically start during
the fall or winter months, but the peak of activity occurs in
January–March (Figure 4), just as we have found for Norway
(Figure 2). In both countries, very few cases are registered in the
summer time. Seasonal variations in immune system responses
have been reported in humans75 and such variations may be
responsible for the increased incidence of infectious diseases
during winter and for the seasonality of non-pandemic inﬂuenza.
Vitamin D modulates the immune system, essentially strengthen-
ing it, in several ways, as reviewed elsewhere.76–80
Norway is located between 60 and 708N, while the center of
population gravity of the USA is located between 35 and 458N. The
seasonal variations in vitamin D photosynthesis are larger for
Norway than for the USA (Figures 2 and 4). Thus, in the USA, as in
Norway, the numbers of deaths are small in the season when
vitamin D status is best.
3.3. Mechanisms behind seasonality
Being the main source of vitamin D, UVB radiation may affect
inﬂuenza via the immune system. It was demonstrated in two
independent studies81,82 that childrenwhowere regularly exposed
to artiﬁcial UVB radiation had around two times lower incidence
rates of upper respiratory tract infections, inﬂuenza, and sore
throat than non-exposed children, and the phagocytic activity of
macrophages increased signiﬁcantly in all exposed subjects in a
dose-dependent manner.
The impact of rurality on morbidity and mortality from the
1918 pandemic inﬂuenza in England, Wales, New Zealand, and
Japan was investigated.83–85 The inﬂuenza morbidity in villages
was higher than or similar to that in towns and cities, while the
mortality appeared to be lowest in villages, revealing signiﬁcant
differences compared to all cities and towns. The differences in
mortality rates between urban and rural regions may be related to
many factors, including differences in vitamin D status. People
living in rural areas have signiﬁcantly higher vitamin D levels
compared to those living in urban areas.86,87
3.4. Seasonal variations in host immunity or in pathogen virulence
An argument for the seasonal effect on the host are that
outbreaks of genetically similar strains occur simultaneously at
similar latitudes across different continents.1 There seems to be, in
many cases, a continuous presence of pathogens throughout the
year.88 Circadian variations of hormones, like melatonin, change
with the season.88,89 This may lead to a seasonal variation in
immunity.89 Thus, mice exhibit circadian variations of suscepti-
bility to pathogens, with the highest susceptibility in the
morning.90
The same virus strain appears to be present in the hosts over
longer periods, two years or more, but leading to manifest disease
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weakening.88 One might expect variations in the immune system
to play a major role. The preventive effect of vitamin D
supplementation against inﬂuenza has also been demonstrated
in intervention studies.11 Furthermore, Ginde et al.91 found that
serum levels of vitamin D were inversely associated with upper
respiratory tract infections.
UV radiation interactswith the immune system in several ways,
as already mentioned. We believe that the main mechanism
involves vitamin D photosynthesis in the skin.
3.5. The inﬂuence of vitamin D on the immune response
Vitamin D plays an important immunomodulatory function in
primates. Deﬁciency has been linked with several autoimmune
diseases, the development of cancer, and an increased risk of
infection.92–96 Better knowledge of the mechanisms through
which vitamin D regulates immune responses is essential for
understanding how it may prevent or reduce the impact of an
inﬂuenza pandemic in humans. Calcitriol, the metabolically active
form of vitamin D, inﬂuences host immunity in two different
important ways: generally it suppresses adaptive immunity,
particularly Th1 cellular immune responses, while it stimulates
innate non-speciﬁc immunity.97
Vitamin D strengthens innate non-speciﬁc immunity in several
different ways. It up-regulates the expression of antimicrobial
proteins (AMPs) like cathelicidins or b-defensins.98,99 The
synthesis of LL-37 antimicrobial peptide (the only humanmember
of the cathelicidin family, an important component of innate
defense) in human macrophages is one of the best known
mechanisms involving vitamin D.98 In addition to its antimicrobial
properties, it is also effective against viruses, including inﬂuenza
virus.100–102 Moreover, vitamin D induces the production of NF-kB
transcription factor inhibitor – IkBa.103 The inhibition of NF-kB
signaling may impair inﬂuenza virus infection. Nimmerjahn
et al.104 showed that human cells with low NF-kB activity were
resistant to inﬂuenza virus infection.
Other non-speciﬁc components of innate immunity regulated
by calcitriol are Toll-like receptors (TLRs) that recognize structur-
ally conserved molecules derived from microorganisms such as
bacteria, viruses, and fungi, and activate immune responses once
an antigen is recognized.105 TLR signaling is strictly linked with
vitamin D. Inﬂuenza A is a single-stranded (ss)RNA virus. (ss)RNA
is a TLR7/8 ligand.106,107 Furthermore, it can induce expression of
the gene coding for the LL-37 peptide.102
While vitamin D may strengthen innate, non-speciﬁc immune
responses and possibly reduce the risk of inﬂuenza virus infection,
attenuation of adaptive immune responses might be linked with
decreased mortality.9 Calcitriol down-regulates secretion of
proinﬂammatory cytokines and up-regulates the release of anti-
inﬂammatory cytokines, hence inﬂuences the Th1/Th2 bal-
ance.108,109 Moreover, it suppresses antigen presentation by
antigen presenting cells (APC) like dendritic cells (DCs) and
macrophages.110,111 Themortality caused by the highly pathogenic
inﬂuenza A virus strains appears to be related to the release of pro-
inﬂammatory mediators.112 Thus, the attenuation of the Th1
immune response by vitamin D might be beneﬁcial for infected
patients.
3.6. Use of vitamin D supplementation to prevent inﬂuenza
Solar radiation contributes signiﬁcantly to vitamin D status. In
temperate regions vitamin D levels are higher in late summer than
in late winter, when the solar radiation contains too little UVB to
synthesize enough vitamin D in human skin. Cannell et al.9,10
hypothesized that wintertime vitamin D insufﬁciencymay explainseasonal variation in inﬂuenza. Two preliminary studies support
this hypothesis.11,113 A randomized controlled trial of bone loss in
postmenopausal, black women found that women given vitamin D
(800 IU/day) were three times less likely to report cold and ﬂu
symptoms than controls given a placebo.11 The intake of high doses
of vitamin D (2000 IU/day) for 1 year efﬁciently protected women
against the ‘typical’ winter colds and inﬂuenza, since only one
patient reported these symptoms.11 Another randomized, double-
blind, placebo-controlled trial, comparing vitamin D supplements
with placebo in schoolchildren, found that intake of vitamin D
(1200 IU/day) during winter and early spring can reduce the
incidence of seasonal inﬂuenza A by a factor of around two, while
this is not true for inﬂuenza B.113
4. Conclusions
Non-pandemic inﬂuenzas usually arrive in winter/early spring,
while the initial wave of pandemic inﬂuenzas may occur in any
season, but with secondary waves in midwinter. Seasonal waves of
all inﬂuenzas are small at low latitudes. It seems likely that
seasonal variations in the incidence and death rates of both
pandemic and non-pandemic inﬂuenza are related to seasonal
variations in vitamin D status. An argument against this hypothesis
might be that inﬂuenza death rates start to increase almost 2
months after the vitamin D levels have reached their minimum.
Similarly, the death rates start to decrease several months before
vitamin D levels start to increase signiﬁcantly. This is likely to be
related to the generation of immunity.
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